✦ LIBER ✦

Bone marrow mononuclear cells for ischemic cardiac failure - a prospective, controlled, randomized, double-blinded study of cell transplantation combined with coronary bypass surgery

✍ Scribed by Pätilä, T.; Lehtinen, M.; Vento, A.; Schildt, J.; Sinisalo, J.; Laine, M.; Hämmäinen, P.; Nihtinen, A.; Alitalo, R.; Nikkinen, P.; Ahonen, A.; Holmström, M.; Lauerma, K.; Pöyhiä, R.; Kupari, M.; Kankuri, E.; Harjula, A.

Book ID: 122291506
Publisher: Informa plc
Year: 2014
Tongue: English
Weight: 259 KB
Volume: 16
Category: Article
ISSN: 1465-3249
DOI: 10.1016/j.jcyt.2014.01.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Isolated Coronary Artery Bypass Graft Co

Isolated Coronary Artery Bypass Graft Combined With Bone Marrow Mononuclear Cells Delivered Through a Graft Vessel for Patients With Previous Myocardial Infarction and Chronic Heart Failure: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

✍ Shengshou Hu; Sheng Liu; Zhe Zheng; Xin Yuan; Lihuan Li; Minjie Lu; Rui Shen; Fu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 876 KB

Comparison of bone marrow mesenchymal st

Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: A double-blind, randomized, controlled trial

✍ Debin Lu; Bing Chen; Ziwen Liang; Wuquan Deng; Youzhao Jiang; Shufa Li; Jing Xu; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 722 KB

Validating intramyocardial bone marrow s

Validating intramyocardial bone marrow stem cell therapy in combination with coronary artery bypass grafting, the PERFECT Phase III randomized multicenter trial: study protocol for a randomized controlled trial

✍ Donndorf, Peter (author);Kaminski, Alexander (author);Tiedemann, Gudrun (author) 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 200 KB

Validating intramyocardial bone marrow s

✍ Donndorf, Peter (author);Kaminski, Alexander (author);Tiedemann, Gudrun (author) 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 200 KB

Rationale and design of the Transendocar

Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy

✍ Barry Trachtenberg; Darcy L. Velazquez; Adam R. Williams; Ian McNiece; Joel Fish 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 322 KB